Want to see SE:ELIC full AI Analyst Report?

Elicera Therapeutics AB (ELIC) Revenue

3 Followers

Elicera Therapeutics AB Revenue

Elicera Therapeutics AB had a revenue of -147.66K in the quarter ending Jun 30, 2026, with -Infinity%. This bring the company's revenue in the last twelve months to -147.66K, Increased -105.48%. In the fiscal year ending Dec 31, 2025, Elicera Therapeutics AB had annual revenue of 0.00 with -100.00% growth.

Revenue (ttm)

-147.66K

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

kr0

Employees

Market Cap

kr184.86M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	―	-7.13M	-100.00%
Dec 31, 2024	7.13M	-4.10M	-36.53%
Dec 31, 2023	11.23M	9.95M	+777.34%
Dec 31, 2022	1.28M	1.28M	+217,957.92%
Dec 31, 2021	587.00	―	+∞%
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―